Sutro Biopharma STRO
NASDAQ STRO
$16.10 +0.07 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Tax Provisions (2022 - 2026)

Updated

Sutro Biopharma (STRO) posted Tax Provisions of $1,000 for Q2 2026, compared with -$18,000 a year earlier.

Analysis

Sutro Biopharma (STRO) Tax Provisions (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Tax Provisions at Sutro Biopharma was -$106,000; for FY2025, it came in at -$100,000.

  • In prior years, Sutro Biopharma's Tax Provisions was $2.4 million in FY2024 (-86.8%), $18.2 million in FY2023 (+628.0%) and $2.5 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Tax Provisions since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.21 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 662.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -291.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 242.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 292.00 Mn
10 Sutro Biopharma 265.72 Mn -412.78 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Dec 31, 2025 -89,000.00
Jun 30, 2025 -18,000.00
Dec 31, 2024 2.39 Mn
Jun 30, 2024 8,000.00
Dec 31, 2023 15.82 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 151,000.00
Mar 31, 2023 395,000.00
Jun 30, 2022 2.50 Mn
API Access

Sutro Biopharma Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=STRO&period=max&api_key=YOUR_API_KEY